A comprehensive review on antibody-drug conjugates (ADCs) in the treatment landscape of non-small cell lung cancer (NSCLC)
Ziad Abuhelwa, Abdurahman Alloghbi, Misako Nagasaka
Topics & Concepts
MedicineTrastuzumabLung cancerImmunotherapyMonoclonal antibodyChemotherapyOncologyDrugCytotoxic T cellCancerAntibody-drug conjugateTargeted therapyInternal medicineAntibodyCancer researchPharmacologyImmunologyBreast cancerChemistryIn vitroBiochemistryHER2/EGFR in Cancer ResearchLung Cancer Treatments and MutationsMonoclonal and Polyclonal Antibodies Research